These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 1559982

  • 1. The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi.
    Eakin AE, Mills AA, Harth G, McKerrow JH, Craik CS.
    J Biol Chem; 1992 Apr 15; 267(11):7411-20. PubMed ID: 1559982
    [Abstract] [Full Text] [Related]

  • 2. Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi.
    Eakin AE, McGrath ME, McKerrow JH, Fletterick RJ, Craik CS.
    J Biol Chem; 1993 Mar 25; 268(9):6115-8. PubMed ID: 8454586
    [Abstract] [Full Text] [Related]

  • 3. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.
    Lima AP, dos Reis FC, Serveau C, Lalmanach G, Juliano L, Ménard R, Vernet T, Thomas DY, Storer AC, Scharfstein J.
    Mol Biochem Parasitol; 2001 Apr 25; 114(1):41-52. PubMed ID: 11356512
    [Abstract] [Full Text] [Related]

  • 4. Leishmania major: comparison of the cathepsin L- and B-like cysteine protease genes with those of other trypanosomatids.
    Sakanari JA, Nadler SA, Chan VJ, Engel JC, Leptak C, Bouvier J.
    Exp Parasitol; 1997 Jan 25; 85(1):63-76. PubMed ID: 9024203
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structural determinants of specificity in the cysteine protease cruzain.
    Gillmor SA, Craik CS, Fletterick RJ.
    Protein Sci; 1997 Aug 25; 6(8):1603-11. PubMed ID: 9260273
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the S(2) subsite specificities of the recombinant cysteine proteinases CPB of Leishmania mexicana, and cruzain of Trypanosoma cruzi, using fluorescent substrates containing non-natural basic amino acids.
    Alves LC, Melo RL, Cezari MH, Sanderson SJ, Mottram JC, Coombs GH, Juliano L, Juliano MA.
    Mol Biochem Parasitol; 2001 Oct 25; 117(2):137-43. PubMed ID: 11606223
    [Abstract] [Full Text] [Related]

  • 10. Cloning and sequencing of tccb, a gene encoding a Trypanosoma cruzi cathepsin B-like protease.
    Nóbrega OT, Santos Silva MA, Teixeira AR, Santana JM.
    Mol Biochem Parasitol; 1998 Nov 30; 97(1-2):235-40. PubMed ID: 9879903
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression in insect cells of active mature cruzipain from Trypanosoma cruzi, containing its C-terminal domain.
    Alvarez V, Parussini F, Aslund L, Cazzulo JJ.
    Protein Expr Purif; 2002 Dec 30; 26(3):467-75. PubMed ID: 12460772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The substrate specificity of cruzipain 2, a cysteine protease isoform from Trypanosoma cruzi.
    dos Reis FC, Júdice WA, Juliano MA, Juliano L, Scharfstein J, Lima AP.
    FEMS Microbiol Lett; 2006 Jun 30; 259(2):215-20. PubMed ID: 16734782
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites.
    Santos VC, Oliveira AER, Campos ACB, Reis-Cunha JL, Bartholomeu DC, Teixeira SMR, Lima APCA, Ferreira RS.
    Sci Rep; 2021 Sep 14; 11(1):18231. PubMed ID: 34521898
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.